The effect of hyperlipidemia and body fat distribution on subclinical left ventricular function in obesity: a cardiovascular magnetic resonance study
Obesity is often associated with multiple comorbidities. However, whether obese subjects with hyperlipidemia in the absence of other complications have worse cardiac indices than metabolically healthy obese su... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - April 2, 2024 Category: Cardiology Authors: Jing Liu, Jing Li, Chunchao Xia, Wenzhang He, Xue Li, Sumin Shen, Xiaoyue Zhou, Nanwei Tong and Liqing Peng Tags: Research Source Type: research
Sex-specific trends in incidence of first myocardial infarction among people with and without diabetes between 1985 and 2016 in a German region
The reduction of myocardial infarction (MI) and narrowing the gap between the populations with and without diabetes are important goals of diabetes care. We analyzed time trends for sex-specific incidence rate... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: Heiner Claessen, Maria Narres, Margit Heier, Tatjana Kvitkina, Birgit Linkohr, Georg Wolff, Michael Roden, Andrea Icks and Annette Peters Tags: Research Source Type: research
Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population
The triglyceride and glucose (TyG) index, a simple surrogate marker of insulin resistance, is related to cardiovascular disease. However, there is a lack of evidence for the relationship between the TyG index ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: Yao Zhao, Yu Gu and Bili Zhang Tags: Research Source Type: research
Evidence that tirzepatide protects against diabetes-related cardiac damages
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective antidiabetic drugs with potential cardiovascular benefits. Despite their well-established role in reducing the risk of major adverse cardiovas... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: Fatemeh Taktaz, Lucia Scisciola, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Giovanni Tortorella, Armando Puocci, Eduardo Sommella, Giuseppe Signoriello, Fabiola Olivieri, Michelangela Barbieri and Giuseppe Paolisso Tags: Research Source Type: research
Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database
The hemoglobin glycation index (HGI) is the difference between the observed and predicted values of glycosylated hemoglobin (HbA1c), which is closely associated with a variety of poor prognoses. However, there... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: Xing Wei, Xinghua Chen, Zhipeng Zhang, Jing Wei, Ben Hu, Nv Long, Jun Feng and Chunmiao Luo Tags: Research Source Type: research
Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study
Diabetes mellitus (DM) duration affects incident atrial fibrillation (AF) risk; the effect of physical activity on mitigating AF risk related to varying DM duration remains unknown. We assessed the effect of p... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: JungMin Choi, So ‑Ryoung Lee, Eue-Keun Choi, Kyung-Yeon Lee, Hyo-Jeong Ahn, Soonil Kwon, Kyung‑Do Han, Seil Oh and Gregory Y. H. Lip Tags: Research Source Type: research
Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients
This study aimed to investigate in humans whether epigenetic signals involved in immune cell activatio... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 29, 2024 Category: Cardiology Authors: Maria Cristina Vinci, Sarah Costantino, Giulia Damiano, Erica Rurali, Raffaella Rinaldi, Vera Vigorelli, Annalisa Sforza, Ermes Carulli, Sergio Pirola, Giorgio Mastroiacovo, Angela Raucci, Assam El-Osta, Francesco Paneni and Giulio Pompilio Tags: Research Source Type: research
Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management
Coronary inflammation plays crucial role in type 2 diabetes mellitus (T2DM) induced cardiovascular complications. Both glucose-lowering drug interventions (GLDIS) and glycemic control (GC) status potentially c... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 29, 2024 Category: Cardiology Authors: Yuankang Liu, Lisong Dai, Yue Dong, Cong Ma, Panpan Cheng, Cuiping Jiang, Hongli Liao, Ying Li, Xiang Wang and Xiangyang Xu Tags: Research Source Type: research
Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus
In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipid... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 29, 2024 Category: Cardiology Authors: Maria Barranco-Altirriba, N úria Alonso, Ralf J. M. Weber, Gavin R. Lloyd, Marta Hernandez, Oscar Yanes, Jordi Capellades, Andris Jankevics, Catherine Winder, Mireia Falguera, Josep Franch-Nadal, Warwick B Dunn, Alexandre Perera-Lluna, Esmeralda Castelbl Tags: Research Source Type: research
Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score ‑matched analysis
This study aimed to investigate the association of sodium-glucose cotransporter 2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes (T2D) patients with acute coronary syndro... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 25, 2024 Category: Cardiology Authors: Tao Liu, Zeyuan Fan, Bing Xiao, Chang He and Shicong Wang Tags: Research Source Type: research
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
Imeglimin is a new anti-diabetic drug which promotes insulin secretion from pancreatic β-cells and reduces insulin resistance in insulin target tissues. However, there have been no reports examining the possib... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 19, 2024 Category: Cardiology Authors: Junpei Sanada, Tomohiko Kimura, Masashi Shimoda, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Yoshiro Fushimi, Yukino Katakura, Yuka Nogami, Yoshiko Shirakiya, Yuki Yamasaki, Tomoko Ikeda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku and Hideaki Kanet Tags: Research Source Type: research
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform f... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 19, 2024 Category: Cardiology Authors: Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Beatriz Fern ández-Fernández, Thomas Forst, Juan-Pablo Frias, James R. Gavin III, Francesco Giorgino, Per-Henrik Groop, Hiddo J. L. Heerspink, Stephan Her Tags: Comment Source Type: research
Postpartum weight retention and the early evolution of cardiovascular risk over the first 5 years after pregnancy
The cumulative effect of postpartum weight retention from each pregnancy in a woman ’s life may contribute to her risk of ultimately developing type 2 diabetes and cardiovascular disease. However, there is limi... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Caroline K. Kramer, Chang Ye, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman and Ravi Retnakaran Tags: Research Source Type: research
Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase II
There is a paucity of contemporary data on the prevalence and prognostic significance of cardiac autonomic neuropathy (CAN) from community-based cohorts with type 2 diabetes assessed using gold standard method... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Timothy M. E. Davis, Eva Tan and Wendy A. Davis Tags: Research Source Type: research
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
(Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk D éruaz-Luyet, Julie M. Paik and Elisabetta Patorno Tags: Correction Source Type: research
